InsidersTradesSigma
Total declarations
Companies
▲ Purchases (7 ops.)
▼ Sales (3 ops.)
Insider track record
Board DirectorDisclosed buys
7
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Burow Kristina, Director. Insider active across 5 companies, notably Beam Therapeutics Inc.. In total, 27 filings have been published. Split: 7 buys · 3 sells. Total volume traded: €6.8m. Activity tracked since 25 June 2021. The latest transaction was filed on 1 July 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Burow Kristina
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations27 total
2,105 shares@ US$53.4940.0017% mcap58.3% of flowCommon StockSEC:0001193125-26-296248:0
948 shares@ US$54.28160.0008% mcap26.6% of flowCommon StockSEC:0001193125-26-296248:1
6,839 shares0Common StockSEC:0001104659-26-071428:0
7,800 shares@ US$26.780.0031% mcap20.5% of flowCommon StockSEC:0001104659-26-048551:0
28,000 shares@ US$4.750.0020% mcap13.1% of flowCommon StockSEC:0001104659-26-048551:1
36,000 shares@ US$9.110.0049% mcap32.2% of flowCommon StockSEC:0001104659-26-048551:2
18,000 shares@ US$8.360.0022% mcap14.8% of flowCommon StockSEC:0001104659-26-048551:3
2,688 sharesCommon StockSEC:0001193125-25-280808:0
1,915,700 shares@ US$2.6165.3% of flowCommon StockSEC:0001012975-25-000681:0
Canonical exit: 25 Jan 2026 (T+90)
1,000 shares@ US$29.2419100.0% of flowCommon StockSEC:0001415889-25-015005:0
7,632 shares0Common StockSEC:0001104659-25-052479:0
16,006,949 sharesCommon StockSEC:0000950170-25-012590:0
13,500 shares0Common StockSEC:0001415889-24-018659:0
20,100 shares0Common StockSEC:0001610717-24-000334:0
589,743 sharesCommon StockSEC:0000950170-24-041844:0
5,339 shares0Common StockSEC:0001062993-23-023195:1
291,906 shares0Common StockSEC:0001062993-23-023195:0
703,061 sharesCommon StockSEC:0001062993-23-022479:0
31,653 shares@ US$11.7515.2% of flowCommon StockSEC:0001062993-23-020934:0
Canonical exit: 11 Feb 2024 (T+90)
69,127 shares@ US$10.7830.4% of flowCommon StockSEC:0001062993-23-020714:0
Canonical exit: 6 Feb 2024 (T+90)
22,420 shares@ US$11.3810.5% of flowCommon StockSEC:0001062993-23-020280:0
Canonical exit: 1 Feb 2024 (T+90)
16,841 shares@ US$13.0620.8% of flowCommon StockSEC:0001062993-23-018633:0
Canonical exit: 27 Dec 2023 (T+90)
34,000 shares@ US$11.7337.6% of flowCommon StockSEC:0001062993-23-018548:0
Canonical exit: 25 Dec 2023 (T+90)
40,000 shares@ US$11.1441.6% of flowCommon StockSEC:0001062993-23-018468:0
Canonical exit: 21 Dec 2023 (T+90)
13,620 sharesCommon StockSEC:0001610717-23-000291:0
25 of 27 declarations
About Burow Kristina
Burow Kristina is Administrateur at Scholar Rock Holding Corp, Neumora Therapeutics, Inc., Metsera, Inc., Beam Therapeutics Inc. and Boundless Bio, Inc. She has 27 filings in total, and across the 27 sampled filings between 2021-06-29 and 2026-07-06, buys total 6586962 EUR and sells total 169894 EUR, with Acquisition as the most frequent transaction nature.
